Filing Details
- Accession Number:
- 0000919574-20-005947
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-21 21:48:26
- Reporting Period:
- 2020-09-17
- Accepted Time:
- 2020-09-21 21:48:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1634432 | Strongbridge Biopharma Plc | SBBP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1325713 | Bruce Kovner | C/O Caxton Corporation 731 Alexander Road, Bldg. 2, Suite 500 Princeton NJ 08540 | No | No | Yes | No | |
| 1388551 | Caxton Corp | 731 Alexander Road Building 2, Suite 500 Princeton NJ 08540 | No | No | Yes | No | |
| 1576081 | Cdk Associates, L.l.c. | C/O Caxton Corporation 731 Alexander Road, Bldg. 2, Suite 500 Princeton NJ 08540 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, $0.01 Par Value | Acquisiton | 2020-09-17 | 1,473,377 | $2.25 | 8,054,682 | No | 4 | P | Direct | |
| Ordinary Shares, $0.01 Par Value | Acquisiton | 2020-09-18 | 6,000 | $2.20 | 8,060,682 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Following the transactions reported herein, these shares represent (a) 7,529,834 Ordinary Shares that are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (b) 530,848 Ordinary Shares beneficially owned by employees of an affiliate of Caxton Corporation and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation.
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.24 to $2.25 per share, inclusive. The Reporting Persons undertake to provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
